A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: In Vitro and in Vivo Exploration

Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells

(2023) Catalina Alamón et al.   Chemical Biology & Drug Design

Carboranes in drug discovery, chemical biology and molecular imaging

(2022) Anita Marfavi et al.   Nature Reviews Chemistry

Tailored therapy for recurrent glioblastoma: report of a personalized molecular approach

(2022) Quintino G. D’ALESSANDRIS et al.   Journal of Neurosurgical Sciences

Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study

(2021) Giuseppe Lombardi et al.   Cancers

Targeted therapy with anlotinib for a H3K27M mutation diffuse middle glioma patient with PDGFR-α mutation: a case report

(2021) Qiang Wang et al.   ACTA NEUROCHIRURGICA

Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro

(2021) Przemysław Biegański et al.   BIOORGANIC CHEMISTRY

Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?

(2021) Paula Aldaz et al.   Cancers

Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism

(2020) Takahiro Nomoto et al.   Science Advances

Small molecule tyrosine kinase inhibitors in glioblastoma

(2020) Gayoung Kim et al.   ARCHIVES OF PHARMACAL RESEARCH

Advances in drug development for targeted therapies for glioblastoma

(2020) Ge Yan et al.   MEDICINAL RESEARCH REVIEWS

Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson’s disease

(2020) Meygal Kahana et al.   MOLECULAR PSYCHIATRY

Bimodal Therapeutic Agents against Glioblastoma, one of the most Lethal Cancer

(2020) Hugo Eduardo Cerecetto et al.   CHEMISTRY-A EUROPEAN JOURNAL

Closo-Carboranyl- and Metallacarboranyl [1,2,3]triazolyl-Decorated Lapatinib-Scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

(2020) Marcos Couto et al.   Cells

Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment

(2020) Martin Gabay et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity

(2020) Catalina Alamón et al.   Cancers

Carboranylanilinoquinazoline EGFR-inhibitors: toward ‘lead-to-candidate’ stage in the drug-development pipeline

(2019) Marcos Couto et al.   Future Medicinal Chemistry

Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets

(2019) Olivia G. Taylor et al.   Frontiers in Oncology

Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons

(2019) Prospero Civita et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Global Burden of Cancer 2013

(2015) Christina Fitzmaurice et al.   JAMA Oncology

Imaging in living cells using νB–H Raman spectroscopy: monitoring COSAN uptake

(2014) Màrius Tarrés et al.   CHEMICAL COMMUNICATIONS

Functional regeneration beyond the glial scar

(2014) Jared M. Cregg et al.   EXPERIMENTAL NEUROLOGY

In vitro studies of cellular response to DNA damage induced by boron neutron capture therapy

(2011) M. Perona et al.   APPLIED RADIATION AND ISOTOPES

A Spectral Window to the Cell

(2010) Peter Hildebrandt   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

First Evaluation of the Biologic Effectiveness Factors of Boron Neutron Capture Therapy (BNCT) in a Human Colon Carcinoma Cell Line

(2010) Maria Alejandra Dagrosa et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Reactive Astrocytes Form Scar-Like Perivascular Barriers to Leukocytes during Adaptive Immune Inflammation of the CNS

(2009) R. R. Voskuhl et al.   JOURNAL OF NEUROSCIENCE

Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

(2008) Michael D. Prados et al.   JOURNAL OF CLINICAL ONCOLOGY